Skip to main content
Erschienen in: Pediatric Cardiology 8/2020

17.08.2020 | Original Article

Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T

verfasst von: Yoshiki Mori, Yasumi Nakashima, Sachie Kaneko, Nao Inoue, Tomotaka Murakami

Erschienen in: Pediatric Cardiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Few reports have described the prognostic value of measuring both B-type natriuretic peptides (BNP) and high-sensitivity troponin T (hs-TnT) in pediatric patients with complex congenital heart disease (CHD) undergoing surgery. We assessed demographic, hemodynamic, and laboratory data, including BNP and hs-TnT levels, for the prediction of cardiac adverse events in 85 patients. Cardiac adverse events were defined as death, cardiac arrest, worsening heart failure requiring inotropic agents and/or respiratory support, and unscheduled surgery/intervention either within or after 12 months of surgery. There were 17 cardiac adverse events. Of the demographic variables, low birth weight (< 2500 g: Odds ratio [OR], 5.97; 95% confidential interval [CI] 1.48–24.0; p = 0.001) and Ross/New York Heart Association [NYHA] class (≥ 2.0) (OR 12.7; 95% CI 3.08–52.7; p = 0.0004) were strongly association with cardiac adverse events. Among hemodynamic and laboratory variables, preoperative BNP (OR 14.04; 95% CI 2.15–91.7; p = 0.001) and hs-TnT levels (OR 16.66; 95% CI 2.27–122; p = 0.002) were found to be independent risk factors. Receiver operating characteristic analysis determined BNP and hs-TnT levels of 60.9 pg/mL and 0.025 ng/mL, respectively, to be markers of high risk. Kaplan–Meier analysis demonstrated significant differences in the freedom from cardiac adverse events between Group A (BNP or hs-TnT elevated, n = 26) and Group B (both biomarkers elevated, n = 19; log-rank, p < 0.001). In conclusion, low birth weight (< 2500 g) and Ross/NYHA class ≥ 2.0 are strongly associated with cardiac adverse events. Preoperative BNP and hs-TnT also provide prognostic information in patients with complex CHD scheduled for surgery. Using both markers in combination predicts cardiac adverse events better than using either separately.
Literatur
12.
15.
Zurück zum Zitat Cantinotti M, Giordano R, Scalese M, Molinaro S, Della Pina F, Storti S, Arceri L, Murzi L, Marotta M, Park V, Poli V, Iervasi G, Clerico A (2015) Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors. Clin Chem Lab Med 53:1839–1846. https://doi.org/10.1515/cclm-2014-1084CrossRefPubMed Cantinotti M, Giordano R, Scalese M, Molinaro S, Della Pina F, Storti S, Arceri L, Murzi L, Marotta M, Park V, Poli V, Iervasi G, Clerico A (2015) Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors. Clin Chem Lab Med 53:1839–1846. https://​doi.​org/​10.​1515/​cclm-2014-1084CrossRefPubMed
16.
20.
38.
Zurück zum Zitat Sugimoto M, Ota K, Kajihama A, Nakau K, Manabe H, Kajino H (2011) Volume overload and pressure overload due to left-to right shunt induced myocardial injury. Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease. Cir J 75:2213–2219. https://doi.org/10.1253/circj.cj-10-1211CrossRef Sugimoto M, Ota K, Kajihama A, Nakau K, Manabe H, Kajino H (2011) Volume overload and pressure overload due to left-to right shunt induced myocardial injury. Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease. Cir J 75:2213–2219. https://​doi.​org/​10.​1253/​circj.​cj-10-1211CrossRef
42.
Zurück zum Zitat Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casa T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdes M, Januzzi JL (2011) Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensate heart failure. Eur J Heart Fail 13:718–725CrossRef Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casa T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdes M, Januzzi JL (2011) Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensate heart failure. Eur J Heart Fail 13:718–725CrossRef
45.
Zurück zum Zitat Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T (2016) Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricular physiology, and systemic morphologically right/left ventricle. Heart Vessels 31:1834–1847. https://doi.org/10.1007/s00380-016-0807-0CrossRefPubMed Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T (2016) Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricular physiology, and systemic morphologically right/left ventricle. Heart Vessels 31:1834–1847. https://​doi.​org/​10.​1007/​s00380-016-0807-0CrossRefPubMed
Metadaten
Titel
Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T
verfasst von
Yoshiki Mori
Yasumi Nakashima
Sachie Kaneko
Nao Inoue
Tomotaka Murakami
Publikationsdatum
17.08.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2020
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-020-02437-5

Weitere Artikel der Ausgabe 8/2020

Pediatric Cardiology 8/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.